Silverback Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Silverback Therapeutics, Inc.
CIK #0001671858
EDGAR Form CIK 2011 - 2025
10-K [0001671858]
10-Q [0001671858]
3 [0001671858]
4 [0001671858]
8-K [0001671858]
D [0001671858]
SC 13D [0001671858]
SC 13G [0001671858]
Form 13D/13G Filer Form 13D/13G Subject Filed
RA Capital Management LP ARS Pharmaceuticals Inc [2023-08-31]
Bell Robert G ARS Pharmaceuticals Inc [2022-11-21]
Tanimoto Sarina ARS Pharmaceuticals Inc [2022-11-18]
Lowenthal Richard E ARS Pharmaceuticals Inc [2022-11-18]
Pratik Shah Living Trust Dated June 15 2011 ARS Pharmaceuticals Inc [2022-11-18]
Flynn James E ARS Pharmaceuticals Inc [2022-11-18]
K2 Principal Fund LP Silverback Therapeutics Inc [2022-07-18]
Wasatch Advisors Inc Silverback Therapeutics Inc [2022-02-11]
US Venture Partners XII LP Silverback Therapeutics Inc [2022-01-27]
Nextech VI Oncology SCSP Silverback Therapeutics Inc [2021-02-16]
View All
Form 3/4/5 Subject 2011 - 2025
ARS Pharmaceuticals, Inc.
Karas Eric
Flynn James E
Deerfield Private Design Fund IV, L.P.
Deerfield Mgmt III, L.P.
Deerfield Management Company LP
Deerfield Mgmt IV, L.P.
Deerfield Private Design Fund III, L.P.
Schneider Phillip M
Dadoo Rajeev
View All
Terms | Privacy | Guide
tony@aum13f.com